NCT01847235 Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial Status COMPLETED Phase PHASE2
NCT01837862 A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT01835145 Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01830101 A Phase III Study of Re-Irradiation in Recurrent Glioblastoma Status WITHDRAWN Phase PHASE3
NCT01827384 MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations Status COMPLETED Phase PHASE2
NCT01824875 Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01800695 Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01790503 A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01781403 Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer Status COMPLETED Phase PHASE1
NCT01777919 Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform Status NOT_YET_RECRUITING Phase PHASE2
NCT01767194 Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Status COMPLETED Phase PHASE2
NCT01765088 A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas Status UNKNOWN Phase PHASE3
NCT01752491 A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01736800 Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors Status WITHDRAWN Phase PHASE2
NCT01735747 Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma Status UNKNOWN Phase PHASE2
NCT01704287 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) Status COMPLETED Phase PHASE2
NCT01700569 Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma Status TERMINATED Phase PHASE1
NCT01649830 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma Status RECRUITING Phase PHASE3
NCT01638546 Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2